We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$41.2B
AUM Growth
+$3.27B
Cap. Flow
-$186M
Cap. Flow %
-0.45%
Top 10 Hldgs %
40.32%
Holding
737
New
74
Increased
253
Reduced
310
Closed
75

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$247M
2
XOM icon
ExxonMobil
XOM
+$200M
3
RTX icon
RTX Corp
RTX
+$193M
4
CVX icon
Chevron
CVX
+$182M
5
QCOM icon
Qualcomm
QCOM
+$166M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$642M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$349M
3
MSFT icon
Microsoft
MSFT
+$204M
4
MCD icon
McDonald's
MCD
+$183M
5
MRK icon
Merck
MRK
+$174M

Sector Composition

Rank Sector Weight
1 Technology 23.1%
2 Healthcare 22.91%
3 Consumer Staples 22.12%
4 Energy 7.11%
5 Communication Services 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HPQ icon
26
HP
HPQ
$23.5B
$416M 1.01%
32,724,684
-11,134,737
-25% -$128M
AMGN icon
27
Amgen
AMGN
$203B
$356M 0.87%
3,122,746
+453,895
+17% +$51.6M
NKE icon
28
Nike
NKE
$61.9B
$339M 0.82%
8,622,656
+256,444
+3% +$9.82M
LLY icon
29
Eli Lilly
LLY
$1.07T
$321M 0.78%
6,302,844
-709,976
-10% -$35.6M
RTX icon
30
RTX Corp
RTX
$287B
$298M 0.72%
4,155,063
+2,831,675
+214% +$193M
EMC
31
DELISTED
EMC CORPORATION
EMC
$268M 0.65%
10,654,322
+3,622,446
+52% +$87.8M
GILD icon
32
Gilead Sciences
GILD
$161B
$255M 0.62%
3,386,737
+464,338
+16% +$32.3M
TGT icon
33
Target
TGT
$62.1B
$252M 0.61%
3,984,185
-1,495,500
-27% -$95.6M
CVS icon
34
CVS Health
CVS
$137B
$239M 0.58%
3,345,354
+442,526
+15% +$28.4M
EBAY icon
35
eBay
EBAY
$48.6B
$229M 0.55%
9,891,371
+6,641,179
+204% +$147M
CPA icon
36
Copa Holdings
CPA
$5.56B
$223M 0.54%
1,393,924
+145,788
+12% +$22M
EMR icon
37
Emerson Electric
EMR
$82.9B
$220M 0.53%
3,129,941
+2,352,259
+302% +$157M
ZBH icon
38
Zimmer Biomet
ZBH
$17.7B
$213M 0.52%
2,356,555
-258,861
-10% -$22.4M
COST icon
39
Costco
COST
$415B
$207M 0.5%
1,736,761
+175,399
+11% +$21M
WBA
40
DELISTED
Walgreens Boots Alliance
WBA
$204M 0.5%
3,555,906
-84,241
-2% -$4.9M
ACN icon
41
Accenture
ACN
$89.9B
$204M 0.5%
2,483,168
+1,535,374
+162% +$116M
BAX icon
42
Baxter International
BAX
$11.6B
$203M 0.49%
5,375,569
+387,825
+8% +$14.1M
MA icon
43
Mastercard
MA
$477B
$202M 0.49%
2,421,210
-648,480
-21% -$48.2M
SYK icon
44
Stryker
SYK
$127B
$198M 0.48%
2,636,722
+340,720
+15% +$24.9M
SYY icon
45
Sysco
SYY
$39.7B
$194M 0.47%
5,384,810
+94,751
+2% +$3.2M
JPM icon
46
JPMorgan Chase
JPM
$939B
$192M 0.47%
3,288,641
+675,181
+26% +$37M
BDX icon
47
Becton Dickinson
BDX
$43.1B
$191M 0.46%
1,775,381
+143,228
+9% +$14.8M
KMB icon
48
Kimberly-Clark
KMB
$36.4B
$184M 0.45%
1,837,070
-91,709
-5% -$9.15M
DHR icon
49
Danaher
DHR
$135B
$182M 0.44%
3,517,050
+1,994,099
+131% +$98M
VALE.P
50
DELISTED
Vale S A
VALE.P
$179M 0.43%
12,744,003
-1,245,455
-9% -$17.7M
1
2
3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2013 Portfolio in Review

As of Q4 2013, Grantham, Mayo, Van Otterloo & Co (GMO) held 737 positions worth $41.2B, up 8.6% from $37.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2013 filing shows 74 new, 253 increased, 310 reduced and 75 closed positions. Its largest new stake was ICICI Bank: 3,782,900 shares worth $25.6M. The largest sale was Pfizer, an estimated $642M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q4 2013 buy was ICICI Bank: 3,782,900 shares worth $25.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to IBM in Q4 2013, an estimated $247M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q4 2013 reduction was Pfizer, cutting an estimated $642M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Vodafone in Q4 2013, selling an estimated $33.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $41.2B portfolio in Q4 2013.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 74 new positions and closed 75 in Q4 2013.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 8.6% quarter-over-quarter to $41.2B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2013, filed 13 Feb 2014.